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ABSTRACT
Despite concerns over the neurocognitive effects of micronutrient deficiencies in infancy, few studies have 
examined the effects of micronutrient supplementation on specific cognitive indicators. This study inves-
tigated, in 2002, the effects of iron-folic acid and/or zinc supplementation on the results of Fagan Test of 
Infant Intelligence (FTII) and the A-not-B Task of executive functioning among 367 Nepali infants living in 
Sarlahi district. Infants were enrolled in a cluster-randomized, placebo-controlled clinical trial of daily sup-
plementation with 5 mg of zinc, 6.25 mg of iron with 25 µg of folic acid, or zinc-iron-folic acid, or placebo. 
These were tested on both the tasks using five indicators of information processing: preference for novelty 
(FTII), fixation duration (FTII), accelerated performance (≥85% correct; A-not-B), deteriorated performance 
(<75% correct and >1 error on repeat-following-correct trails; A-not-B), and the A-not-B error (A-not-B). At 
39 and 52 weeks, 247 and 333 infants respectively attempted the cognitive tests; 213 made an attempt to 
solve both the tests. The likelihood of females completing the A-not-B Task was lower compared to males 
when cluster randomization was controlled [odds ratio=0.67; 95% confidence interval 0.46-0.97; p<0.05]. 
All of the five cognitive outcomes were modelled in linear and logistic regression. The results were not 
consistent across either the testing sessions or the information-processing indicators. Neither the com-
bined nor the individual micronutrient supplements improved the performance on the FTII or the A-not-B 
Task (p>0.05). These findings suggest that broader interventions (both in terms of scope and duration) are 
needed for infants who face many biological and social stressors.
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INTRODUCTION
In recent years, the micronutrients—iron and 
zinc—have received increased attention due to their 
role in facilitating the growth and development of 
children. Beginning at six months, children require 
amounts of zinc and iron that cannot be met by 
breastmilk alone (1). Children who are fed a pre-
dominately plant-based diet often have difficulty 
in obtaining iron and zinc in a sufficient quantity 
because the nutrients in plant-based foods, such as 
green-leafy vegetables (iron) and grains (zinc), are 
not easily absorbed (2). In Nepal, serum concentra-
tions of zinc have revealed high levels of zinc defi-
ciency (3), and iron-deficiency anaemia (IDA) was 
found in 48% of children aged less than two years 
(4).
Both iron and zinc are needed for brain function 
and are found in areas of the brain that are respon-
sible for higher intellectual functioning (5-8). Iron 
is a co-factor in enzymes involved in neurotrans-
mitter synthesis and is required for myelination, 
which ensures proper neuronal signal conduction 
(5). Zinc is one of the most ubiquitous metals in the 
brain and is present in many enzymes involved in 
brain growth, proteins for neurotransmission, and 
in neurotransmitters used for brain memory func-Siegel EH et al. Iron and zinc supplementation and infant cognition
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tion (6,8). The presence and the location of iron 
and zinc in the brain, together with evidence on 
their role in neurotransmission, indicate that both 
metals are important for optimal neural function 
and cognition.
In turn, deficiencies in iron and zinc are associ-
ated with decreased cognitive functioning. Evi-
dence  from  iron-repletion  and  supplementation 
trials demonstrates that children with IDA perform 
worse than children without IDA on developmen-
tal indices—both mental (9-12) and motor (13). 
Mixed results were found in zinc-supplementation 
trials among children aged less than two years. 
Among the studies that examined the traditional 
sensorimotor outcomes (e.g. Bayley and Griffiths 
Scales), two revealed differences (14,15) and two 
found no differences (16,17) between zinc-sup-
plemented and unsupplemented infants. One of 
these studies discovered that zinc-supplement-
ed infants performed better (14) whereas an-
other found that they did worse (15). In studies 
that examined the effect of zinc supplementa-
tion on different outcomes, including activi- 
ty level, behaviour, and posture, each found that 
zinc-supplemented children performed better than 
unsupplemented children (16,18,19). Selection of 
an appropriate test is a key to understanding how 
cognition develops in the young child—both in 
conditions of optimal nutritional status and when 
micronutrient deficiencies occur.
Cognition is a complex construct not fully captured 
by general tests of sensorimotor development [i.e. 
the Bayley Scales of Infant Development (20)] that 
are increasingly recognized as having poor con-
struct and predictive validity in children aged less 
than two years (21,22). On the other hand, specific 
tests of the infant’s information processing (atten-
tion, recall, and executive function) are predictive 
of performance on language-based intelligence tests 
in older children and adolescents (23-25) but have 
had a limited use in micronutrient studies focused 
on infants’ cognition. 
We examined the effects of supplementation with 
iron-folic acid and/or zinc on the information 
processing of 39- and 52-week-old Nepali children 
using a randomized placebo-controlled design. 
We specifically investigated how rural Nepali chil-
dren perform on information-processing tests, and 
whether supplementation with iron-folic acid and/
or zinc results in better scores on these measures.
MATERIALS AND METHODS
Study subjects
The study was conducted on a sub-sample of chil-
dren drawn from a large community-based trial of 
daily supplementation of iron-folic acid and zinc 
designed to investigate the effects of daily supple-
mentation with iron-folic acid and zinc on mortali- 
ty (3,26). Families were identified as eligible for the 
large trial from a census conducted by the study 
personnel during December 2000–March 2001. 
Children were enrolled in the trial during October-
December 2001 following the caregiver’s verbal 
consent. For the present study, a single village de-
velopment committee (VDC) in Sarlahi district in 
south central Nepal was selected to investigate the 
effects of iron-folic acid and zinc supplementation 
on the developmental outcomes. The religious 
and caste groups represented in this sub-sample 
included: Brahmins, Chhetris, Vaiyshas, Shudras,   
and Muslims. 
Developmental, nutritional status, and socioeco-
nomic measurements for the child development 
sub-study were collected during January-March 
2002. A sub-set of children enrolled in the child 
development sub-study (eligibility was determined 
based on age) was invited to participate in a cog-
nitive-testing protocol when they turned 39 and 
52 weeks of age between January and November 
2002. These age criteria are dictated by the Fagan 
Test of Infant Intelligence (FTII)—one of the meas-
ures used. After verbal consent from caregivers, 
259 children were eligible to receive both the tests, 
and 104 children, older than 39 weeks at the study 
launch, were eligible to receive only the 52-week 
test (Fig. 1). Children whose ages were within the 
test window at the beginning of the study received 
the information-processing measures before the 
developmental, nutritional status, and socioeco-
nomic measurements (Fig. 2). 
The study was approved by the Johns Hopkins 
Bloomberg School of Public Health and the Nepal 
Health Research Council and is registered at Clini-
caltrials.gov (NCT #00109551). 
Assessment of cognitive development, 
nutritional status, and sociodemographics
Cognitive development was evaluated using the 
information-processing measures that were part of 
the FTII (27) and the A-not-B Task (28,29). Children 
were scheduled for the FTII and the A-not-B Task at 
the same time during a two-week window around 
39 and 52 weeks, assuming term delivery. Only 
children aged 53 weeks or less at baseline were eli-
gible for these assessments. The tests were admin-
istered in mid-morning in the field office—the A-
not-B Task before the FTII. Three local fieldworkers 
achieved at least 85% on inter-rater reliability after 
being trained to conduct the tests. Iron and zinc supplementation and infant cognition Siegel EH et al.
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Fig. 1. Eligibility and attrition of participating children
Eligible* for both
39- and 52-week visits:
n=259
Attempted†,¶ only
39-week test: 
n=34
Completed¶,§ only
39-week test:  
FTII: n=31, A-not-B: n=29
Attempted†,¶ both
39- and 52-week tests:
and n=213
Completed¶,§ both
39- and 52-week tests:
     FTII: n=209, A-not-B: n=167
Eligible* for only
52-week visit:
n=104
Attempted†,¶ only
52-week test:
n=120
Completed¶,§ only
52-week test:
     FTII: n=117, A-not-B: n=98
*Children were considered ineligible for the test if their age was greater than 39 weeks in one subset or 52 
weeks for another at the start of the study; †Eligible children did not attempt the test for the following 
reasons: they were unable to be contacted after multiple attempts and missed the visit (n=24); the family 
refused to participate (n=6); and the family moved (n=12); ¶The A-not-B data gathered from the attempt 
were sufﬁcient to run the models; §Children who attempted the tests were not able to complete it for the 
following reasons: child closed his/her eyes (n=1), turned to mother’s breast (n=2), looked away (n=14), 
fussed (n=19), did not engage with tester (n=46), not able to pick up cloth or toy (n=17), and other (n=3)
Fig. 2. Timeline of study activities
January
2002
November
2002 
Information-processing tests administered 
March
2002 
Descriptive
data collected*,†
Supplementation initiated after descriptive
data-collection†
*The descriptive data included developmental, 
nutritional status, and socioeconomic status data; 
†31% of the 39-week infants and 24% of the 52-
week infants were administered the information-
processing tests before the descriptive data- 
collection due to study logistics
The FTII, a paired-comparison test, measures the 
span of time an infant views a familiar stimulus, 
identifies it as familiar, and shifts his attention to a 
novel stimulus (27,30). The FTII generates the pref-
erence for novelty score—time spent looking at the 
novel stimuli divided by the time spent looking at 
both novel and familiar stimuli, a computation 
that the program calculates automatically. An-
other measure—fixation duration—was defined as 
time spent attending to the stimuli and was in-
dicative of information-processing time. Fixation 
duration was calculated by dividing the sum of the 
time spent looking at the left stimulus by the sum 
of time spent looking at the right stimulus. These 
data are automatically generated by the FTII pro-
gram. A faster processing time is indicative of more 
advanced development. 
The A-not-B Task measures the ability of an infant 
to recognize objects as being permanent and sepa-
rate from the child (29). The concept of object per-
manence was described by Piaget as being one of 
the infant’s most important accomplishments (30).   
In the A-not-B Task, a toy is hidden in one of two 
wells of the test apparatus, and the child is tasked 
to find it. To ensure that the challenge is age-appro-
priate, a time-delay may be imposed by the tester 
between hiding the toy and allowing the child to 
reach for it. In this study, the testers administered   
1-3-second delay at all ages that increased by two 
seconds after the first three correct trials for 3-5 sec-
onds. 
Two types of trials are administered in this task: one 
in which the hiding location remains the same as 
on the previous trial and one in which the hiding 
location reverses (reversal trial). The A-not-B error 
occurs when the child fails to look for the toy in 
the new hiding place on a reversal trial and instead 
looks for the toy in the previous location. It has 
been proposed that the error reveals the child’s in-
ability to inhibit a previously-rewarded search and/
or remember the new location (31).
The study children were marked as having made 
the A-not-B error if the following conditions were 
present: (a) no more than one error on a repeat-
following-correct trial (the side of hiding remains 
the same, and the child was correct on the previous 
trial); (b) at least one error on a reversal trial; and (c) 
either an error on one more reversal trial or an er-
ror on the trial immediately following the reversal 
error. Children were classified as having accurate Siegel EH et al. Iron and zinc supplementation and infant cognition
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performance when they were able to locate the toy 
on at least 85% of the trials. They experienced dete-
riorated performance when they found the toy on 
less than 75% of the trials and had more than one 
error on repeat-following-correct trials (31). A re-
peat-following-correct trial occurred when the side 
of hiding remained the same, and the subject was 
correct on the previous trial. The maximum correct 
delay was the maximum time of the delay imposed 
that resulted in a correct trial. A-not-B flag meant 
that at least one of the following conditions was 
present during the trial: (a) the tester uses only one 
well for the trial (instituted after the child missed 
the five previous trials); (b) the child uncovers both 
the wells at once; and (c) child partially reaches 
to uncover the well, and/or self-corrects when at-
tempting to find the hidden toy.
The field workers performed the procedures for 
measuring anthropometry, drawing blood, and 
assessing socioeconomic status on a different day   
other than the cognitive tests. They completed 
daily quality-control assessments following stand-
ardized procedures to test the reliability of the 
equipment during this phase of data-collection. 
Weight was measured to the nearest 0.1 kg using 
a SECA floor scale (Seca Corporation, Hanover, 
Maryland, USA). Recumbent length was measured 
in triplicate to the 0.01 cm using a Shorr Board for 
length (Shorr Productions, Olney, Maryland). Three 
drops of blood were collected from each child us-
ing a heel prick. The first drop was wiped away, 
and the second and third drops were used for test-
ing haemoglobin and erythrocyte protoporphy-
rin (EP) respectively using a haemoglobin pho-
tometer (HemoCue AB, Andelholm, Sweden) 
and a Hematoflurometer (AVIV Biomedical Inc., 
New Jersey, USA). The child’s house was assessed 
for construction materials, water source, and the 
presence of material assets. Basic demographic in-
formation, including the child’s sex, caste/religion, 
and birth date, was also documented  from  the 
caregiver’s reports. When the caregivers were un-
able to remember the exact month and day of the 
child’s birth, local calendars with the lunar cycle 
and a list of local festivals were used as aids. A time-
line of the study activities is presented in Figure 2.
Randomization and supplementation
In the larger 2x2 factorial trial, the unit of randomi-
zation was a geographic sector, with several sectors 
comprising a VDC. Randomization was stratified by 
the VDC. Randomization for the 23 sectors within 
Ishwarpur VDC was carried out in 6 blocks of 4. The 
code assignments (A, B, C, or D) were determined 
from repeated drawing from a pool of all possible 
letter combinations. Hence, randomization was 
preserved within this selected VDC. All children 
living in a given sector were given the same supple-
ment, facilitating the distribution of appropri-
ate supplements by the field workers. Neither the 
families of the participants nor the research team 
were able to trace the code assignments to the sup-
plements. 
Children received: 6.25 mg of iron sulphate and 25 
µg of folic acid, 5 mg of zinc sulphate, both iron 
sulphate-folic acid and zinc sulphate, or placebo; 
these doses correspond to half of a typical dose 
given to children aged over 12 months. The dura-
tion of supplementation for children who complet-
ed the 39-week assessments ranged from 0 to 24 
weeks, and for those completing the 52-week visit, 
supplementation lasted from 0 to 37 weeks. Chil-
dren consumed 0 to 237 supplements before re-
ceiving the information-processing tests. This 
variable duration was dictated by the need to test 
infants in the sub-study at the precise ages of 39 
and 52 weeks. All children aged 1-35 months at the 
start of the larger trial were eligible for that trial.
Analysis of data
Data were analyzed using the SPSS software (ver-
sion 14.0) and the Stata software (version 8.0). The 
39- and 52-week test data were analyzed separately. 
The preferences for novelty and fixation duration 
were extracted from the FTII program using the SAS 
software. The preference for novelty was described 
by the raw FTII score. A-not-B error, percentage of 
accurate performance, and percentage of deterio-
rated performance from the A-not-B Task are de-
fined above. 
The z-scores were calculated for three of the an-
thropometric measures using the 1978 Centers 
for Disease Control and Prevention (CDC)/World 
Health Organization (WHO) growth reference in 
the Epi Info software (version 6.0) (CDC, Atlanta, 
GA) to facilitate comparison with previous stud-
ies published using data from the same popula-
tion (4,32-34). Stunting, wasting, and underweight 
were defined respectively as height-for-age (LAZ), 
weight-for-length (WLZ), and weight-for-age (WAZ) 
<-2 z-scores. 
Principal component analysis was used for creat-
ing a socioeconomic status (SES) scale (35) from the 
questions on material assets and home amenities. 
The most comprehensive factor with the largest 
eigen value of >1 was selected. Twelve of the 17 re-
lated items were retained for the SES scale: presence 
of a latrine, servant, cattle, bicycle, radio, farm-
able land, home-garden plot, second floor on the 
house, roof material, television, electricity inside 
the house, and cart. Chronbach’s alpha (36) of 0.78 Iron and zinc supplementation and infant cognition Siegel EH et al.
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was obtained, indicating good internal consistency. 
A higher score on the SES scale reflected a greater 
number of possessions. For regression models, the 
SES variable was dichotomized at the median, crea- 
ting respectively low and high SES groups. 
Fixation duration was log-transformed to create 
normal distributions. The significance was set at 
p<0.05 for the covariates to be entered and retained 
in the final model. Means of continuous variables 
and proportions of categorical variables were ana-
lyzed using t- and chi-square tests. 
We hypothesized that the study children enrolled 
in the treatment group compared to the placebo 
group would have a higher percentage of novelty 
scores, shorter fixation-duration times, fewer A-
not-B errors, a greater percentage of accurate per-
formance, and less deteriorated performance. To 
test this, we calculated means and medians for the 
information-processing outcomes to test the po-
tential differences between the treatment groups. 
The data were analyzed using the 2x2 factorial de-
sign and were then tested for the individual group 
differences for each of the outcomes. After finding 
no differences between the two methods, we chose 
to present the individual group differences for clari-
ty. We created intention-to-treat linear and logistic 
models for each outcome with adjustment for clus-
ter randomization only and then with adjustment 
for additional covariates by which the treatment 
groups differed before supplementation. Cluster 
randomization was achieved using generalized esti-
mating equations (GEE) (37).   
RESULTS
The number of children who were eligible for the 
information-processing tests, later attempted and 
completed the FTII and A-not-B Task at 39 and 52 
weeks, is presented in Figure 1. Descriptive charac-
teristics, including sex, caste, SES, anaemia, IDA, 
and anthropometry did not differ (p>0.05) between 
children who completed and did not complete the 
tests (data not shown). However, when cluster ran-
domization was controlled in a logistic regression 
model, the likelihood of females completing the 
A-not-B Task was lower than it was for males [odds 
ratio (OR)=0.67, 95% confidence interval (CI) 0.46-
0.97, p<0.05]. When the supplementation groups 
were added to the above model, children who were 
enrolled in the supplementation groups were not 
found to differ from the children enrolled in the 
placebo group with respect to completing the A-
not-B Task (data not shown). 
Before the supplementation, 55% of the study in-
fants were anaemic [haemoglobin (Hb) <105 g/L], 
44% had IDA (Hb <105; erythrocyte protoporphy-
rin >90 µmol/mole heme), 22% were stunted [LAZ 
<-2 standard deviation (SD)], 13% were wasted 
(WLZ <-2 SD), and 42% were underweight (WAZ 
<-2 SD). 
Despite randomization stratified at the VDC level, 
the four treatment groups differed before supple-
mentation (Table 1). The zinc group was younger 
(52 weeks) and had more girls (39 weeks), families 
with a greater number of possessions (SES) (39 and 
52 weeks), higher Hb values (39 and 52 weeks), and 
lower prevalence of anaemia and iron deficiency 
(39 and 52 weeks) (all p<0.05, Table 1). Children 
consumed supplements, on average, 5-7 days per 
week once supplementation began. No interac-
tions between iron and zinc were found. Supple-
ment dose was not found to be a significant pre-
dictor of performance in any of the models when 
entered either as a continuous or as a categorical 
variable (dichotomized as greater than or less than 
two months of supplementation before the test).
The FTII
Compared to the 39-week infants, the 52-week in-
fants had better mean FTII scores; they were one 
point higher on preference for novelty and 0.05 
seconds faster on fixation duration (Table 2). In lin-
ear regression models adjusted for cluster randomi-
zation, the zinc-iron-folic acid group compared to 
the placebo group scored lower on preference for 
novelty at 52 weeks (Table 3). Lower preference for 
novelty in this group, compared to placebo at 52 
weeks, remained significant after the models were 
further adjusted for sex, caste, and the number of 
supplements received (Table 4). 
The A-not-B Task
The 52-week-old infants scored better than the 39-
week-old infants on two of the three A-not-B Task 
measures (Table 2). Their mean accurate perform-
ance score was six percentage points higher, and 
their deteriorated performance score was seven 
percentage points lower than the 39-week infants. 
However, despite having the same delay, the 52-
week-old infants demonstrated more A-not-B errors 
than the 39-week-old infants (Table 2). In logistic 
models that controlled for cluster randomization 
only, the zinc-iron-folic acid group had higher 
likelihood of accurate (OR=2.94, CI 1.47-5.91) and 
lower likelihood of deteriorated (OR=0.35, CI 0.15-
0.84) performance at 39 weeks compared to the 
placebo. However, at 52 weeks, this group had 
84% higher odds (CI 1.04-3.26) of committing the 
A-not-B error than the placebo (p<0.05) (Table 3).
Multiple logistic regression models adjusted 
for cluster randomization, gender, caste, A-not-B Siegel EH et al. Iron and zinc supplementation and infant cognition
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Table 1. Characteristics of infants randomized to treatment groups
  Characteristics
39-week visit
Zinc Iron/folic acid Zinc/iron/folic acid Placebo
Age (months) at enrollment1 7.1 (2.1) 7.5 (2.0) 7.1 (2.3) 7.1 (2.4)
% of females*  57.8 40.3 34.3 50
% of low-caste Hindus  75.8 87.1 75.8 60.7
% of Muslims 4.7 9.7 15.7 30.6
% of low SES score, below 
median2** 22.0 57.1 40.3 40.3
% of stunted infants3  14.9 10.3 15.3 26.3
% of wasted infants4 14.9 6.7 12.9 1.8
% of underweight infants5 26.1 31.0 36.5 36.8
Haemoglobin1*** 110.3 (10.2) 100.6 (12.0) 102.2 (14.6) 102.0 (11.1)
% of haemoglobin <1056** 25.5 61.7 47.7 57.5
EP1* 81.7 (29.2) 129.1 (76.4) 122.8 (85.8) 108.0 (94.6)
% of EP >907**  29.8 66.7 55.4 45.8
No. of supplements received1 29.4 (28.0) 26.6 (27.7) 33.4 (32.7) 25.6 (29.4)
52-week visit
Age (months) at enrollment1* 7.9 (2.7) 9.1 (2.8) 8.7 (3.0) 8.4 (3.0)
% of females  57.0 39.6 44.0 52.9
% of low-caste Hindus*** 75.3 88.4 80.0 67.1
% of Muslims*** 6.3 8.3 16.0 27.6
% of low SES score, below 
median2*** 25.7 54.7 48.5 42.4
% of stunted infants3 14.5 19.3 25.9 25.0
% of wasted infants4  21.8 11.4 10.1 12.5
% of underweight infants5 32.1 40.4 44.0 48.7
Haemoglobin1*** 109.1 (10.5) 101.1 (9.7) 102.0 (13.1) 101.5 (10.3)
% of haemoglobin <1056** 32.7 65.2 53.2 56.8
EP1** 89.4 (57.0) 130.3 (74.5) 129.8 (82.0) 114.5 (89.2)
% of EP >907*** 34.5 68.5 62.8 54.9
No. of supplements received1 67.0 (53.9) 50.3 (53.5) 58.9 (60.5) 54.2 (55.5)
*p<0.05; **p<0.01; ***p<0.001; 1Values shown as mean (standard deviation), 2Number of assets; median=4 
possessions;  3Length-for-age z-score <-2 standard deviations;  4Weight-for-length z-score <-2 standard 
deviations; 5Weight-for-age z-score <-2 standard deviations; 6Units given in g/L; 7Units given in µmol/
mole heme; EP=Erythrocyte protoporphyrin; SES=Socioeconomic status
flag, maximum delay, and the number of supple-
ments received before the test revealed that, at 
39 weeks, children receiving zinc-iron-folic acid 
had lower odds of both accurate and deteriorat-
ed performance than children who received a pla-
cebo. At 52 weeks, the zinc-iron-folic acid group 
compared to the placebo group had lower odds 
of accurate performance and of committing the A-
not-B error (Table 4).                 
DISCUSSION
We examined the effect of micronutrient supple-
mentation at two time-points on five indicators of 
information processing in infants and found that 
zinc-iron-folic acid supplementation was associa- 
ted with lower accuracy of performance at both 
the time-points, less deteriorated performance at 39 
weeks, and fewer A-not-B errors at 52 weeks when 
the performance was adjusted for unbalanced ran- 
domization. Neither the combined nor the indi- 
vidual micronutrient supplements improved the 
performance on the FTII or the A-not-B Task.
Although we were able to administer both the tests 
in our remote field setting, the FTII required less ef-
fort from the child and was easier than the A-not-B 
Task to administer. We aligned the administration 
of both the tasks to coincide with the FTII eligibility 
because the FTII had a narrower window of eligibi-
lity than the A-not-B Task. However, we expected 
that some children received the FTII tests earlier 
than indicated, since it is possible that their true Iron and zinc supplementation and infant cognition Siegel EH et al.
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Table 2. Descriptive statistics for 39- and 52-week testing periods
  Test
39-week visit
Variable No. Mean (SD)/No. (%) Minimum Maximum
FTII Preference for novelty 244 60.05 (6.16) 38.1 74.3
FTII Fixation duration 233 0.319 (0.229) -0.2 1.1
A-not-B Task A-not-B error 202 48 (23.8)
A-not-B Task Accurate performance 200 74 (37)
A-not-B Task Deteriorated performance 200 43 (21.5)
A-not-B Task Neither accurate nor 
deteriorated 200 83 (41.5)
52-week visit
FTII Preference for novelty 325 61.0 (6.0) 40.8 78.2
FTII Fixation duration 323 0.271 (0.18) -0.14 0.95
A-not-B Task A-not-B error 264 71 (26.9)
A-not-B Task Accurate performance 256 111 (43.4)
A-not-B Task Deteriorated performance 256 37 (14.5)
A-not-B Task Neither accurate nor 
deteriorated 256 108 (42.2)
Preference for novelty: Raw FTII score. Fixation duration: Time spent attending to the stimuli. A-not-B 
error: No more than 1 error on repeat-following-correct trial, at least 1 error on a reversal trial and either 
an error on at least one more reversal trial or an error on the trial immediately following the reversal 
error. Accurate performance: ≥85% correct. Deteriorated performance: <75% correct; >1 error on repeat-
following-correct trials. Repeat-following-correct: Side of hiding remains same, and the subject was 
correct on previous trial; FTII=Fagan Test of Infant Intelligence; SD=Standard deviation
gestational age was shorter than the 40 weeks we 
assumed. In this setting, accurate gestational age is 
difficult to determine due to the rural and impover-
ished setting; neither the date of the last menstrual 
period (LPM) nor the true gestation age may be 
established. Given the study design, the pertinent 
comparison of the scores was between the supple-
mented group and the placebo group. The Nepali 
children’s preference for novelty scores on the FTII 
were comparable with those measured in a Chilean 
sample of one-year old children (Nepal: 61.04 vs 
Chile: 61.9) (38).      
The A-not-B Task was more difficult for the Nepali 
children to comprehend than the Fagan Test as 
many displayed signs of fatigue and stopped res-
ponding before the test was complete. Although 
many went on to complete the task, it is possible 
that the power was compromised. There is no 
standard protocol for administering the A-not-B 
Task, which makes cross-study comparisons very 
difficult. Testers who use this task impose a delay 
that is typically increased with age to ensure that 
the child is continually challenged (34). Despite 
having the same delay for the 39- and 52-week old 
infants in the Nepal study, the older children had a 
larger percentage of A-not-B errors, which is surpris-
ing and indicates possible problems for the older 
children. Nevertheless, the 52-week old infants ap-
peared to benefit from zinc-iron-folic acid supple-
mentation in having a lower likelihood of commit-
ting the A-not-B error.  
The finding that males were more likely to com-
plete the A-not-B Task than females mirrors recent 
findings on spatial ability that have shown gender 
differences as early as infancy (39,40). Spatial abili- 
ty was required of the children to perform the A-
not-B Task; however, the effect disappeared once 
the data were adjusted for caste and socioeconomic 
status. The sex differences that were revealed when 
the data were adjusted for cluster randomization 
but not when caste and socioeconomic status were 
adjusted can be attributed to confounding. 
Many factors potentially affect the relationship be-
tween the nutritional status and the poor develop-
mental outcomes. These include low SES (41,42), 
lack of stimulation in the home (43), poor mater-
nal education (44,45), low birthweight (45), and 
lower rates of breastfeeding and early weaning (9). 
We differentiated between the low and the high 
SES; however, the differences were not large. Our 
SES measure revealed that few material resources 
were available in this population. Furthermore, 
only 25% of women living in the study area were 
reported  to  be  literate  (3,26).  Birthweight  was 
not measured in this study. However, based on 
previous research, we expect that a large percent-
age of our study children had low birthweight Siegel EH et al. Iron and zinc supplementation and infant cognition
JHPN 600
(46,47). Preliminary research revealed that 95% of 
our study subjects were breastfeeding and that few 
complementary foods were introduced during the 
first year of life (4,32). In this impoverished en-
vironment where the study participants were liv-
ing in the presence of an ongoing civil insurgency 
and other risk factors, low-level supplementation 
of micronutrients may not have been sufficient to 
improve information processing in these infants.
Other limitations that could have affected the re-
sults of the study include the selection of a purpo-
sive sub-sample from a large cluster randomized 
trial, the choice to randomize at the sector level 
and analyze the data at the individual level, and the 
variation in supplement dose that occurred when 
trying to administer the cognitive testing within 
the methodological framework of a larger study. 
We controlled for cluster randomization in each of 
the models, used an intent-to-treat analysis, and 
further controlled for the baseline characteristics 
that differed among the treatment groups, despite 
the randomization and supplement dose. Options 
for working within the context of a developing 
country are often limited. However, in light of the 
paucity of data on specific cognitive functions in 
very young micronutrient-deficient children, our 
study provides important findings on measures of 
information processing. 
Few other researchers have used the information-
processing outcomes to measure the cognitive dif-
ferences in young children supplemented with zinc 
and iron. In fact, as far as we know, there are no 
studies on these outcomes in zinc-supplemented 
individuals. Research conducted with Mexican-
American school children and men found that 
zinc had an impact on attention and memory 
(48). With respect to iron, a non-randomized study 
among Chilean full-term infants examined the ef-
Table 3. Effect of supplementation on mean FTII scores and A-not-B Task odds ratios at 39 and 52 
weeks of age from multivariate models adjusted for cluster randomization
Test
39-week visit
Outcome Placebo
OR (95% CI) 
Zinc 
OR (95% CI)
Iron-folic acid 
OR (95% CI)
Zinc-iron-folic acid 
OR (95% CI)
FTII Preference for 
novelty1
60.76
(59.51-60.01)
58.76
(56.80-60.72)
60.80
(59.46-62.15)
60.08
(58.21-61.94)
FTII Fixation 
duration2
1.40
(1.26-1.56)
1.39
(1.33-1.46)
1.30
(1.26-1.35)
1.41
(1.33-1.49)
A-not-B Task A-not-B error3 1.0 0.81
(0.38-1.74)
0.67
(0.17-2.57)
1.42
(0.54-3.73)
A-not-B Task Accurate 
performance4 1.0 1.31
(0.52-3.27)
1.11
(0.48-2.55)
2.94
(1.47-5.91)6
A-not-B Task Deteriorated 
performance5 1.0 0.66
(0.29-1.52)
1.37
(0.52-3.58)
0.35
(0.15-0.84)6
52-week visit
FTII Preference for 
novelty1
62.06
(60.98-63.14)
61.37
(58.46-64.28)
61.40
(60.21-62.58)
60.0
(59.03-60.97)6
FTII Fixation 
duration2
1.30
(1.27-1.36)
1.31
(1.27-1.36)
1.30
(1.28-1.33)
1.32
(1.28-1.37)6
A-not-B Task A-not-B error3
1.0 1.47
(0.80-2.69)
1.38
(0.93-2.04)
1.84
(1.04-3.26)6
A-not-B Task Accurate 
performance4 1.0 0.89
(0.50-1.60)
0.91
(0.50-1.70)
0.83
(0.50-1.36)
A-not-B Task Deteriorated 
performance5 1.0 1.06
(0.58-1.94)
0.98
(0.48-1.99)
0.88
(0.34-2.26)
1Preference for novelty: Raw FTII score; 2Fixation duration: Time spent attending to the stimuli; 
3A-not-B error: No more than 1 error on repeat-following-correct trial—at least 1 error on a reversal 
trial and either an error on at least one more reversal trial or an error on the trial immediately 
following the reversal error. Repeat-following-correct: Side of hiding remains same and subject was 
correct on previous trial; 4Accurate performance: ≥85% correct; 5Deteriorated performance: <75% 
correct; >1 error on repeat-following-correct trials; 6p<0.05; CI=Confidence interval; FTII=Fagan   
Test of Infant Intelligence; OR=Odds ratioIron and zinc supplementation and infant cognition Siegel EH et al.
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fects of no-added iron, low- or high-added iron on 
the FTII and found a positive effect of iron supple-
mentation compared to the ‘no-added iron’ group 
on fixation duration (36) but not on preference 
for novelty. Chilean infants supplemented with 
high versus low-iron for six months had shorter 
fixation duration (38). In comparison, the par-
ticipants in this study were randomized, and the 
study itself was conducted in a more impoverished 
environment. Nepal is classified as one of the least-
developed and poorest nations in the world (49).
The use of randomized, placebo-controlled clini-
cal trials and specific information-processing tests 
are keys to understanding the associations between 
micronutrient status and cognitive function in 
young preverbal children. The primary strengths 
of this study were the use of two specific measures 
of information processing—the FTII and the A-not-
B-Task, as opposed to the more commonly-used 
sensorimotor tests of infant development. This 
study evaluated the information processing of 
young children during the first year of their life in 
a developing-country setting where cognitive de-
velopment is rarely investigated. A randomized 
trial design was used for reducing the likelihood 
of bias; however, there were still some differences 
by treatment group at baseline. These were ad-
justed for in the final analysis. It is possible that 
there may be some residual bias from factors not 
adjusted for but this is not likely to fully explain 
the results, since both randomization and adjust-
ment were applied to the design and analysis. In 
sum, the evidence from this experimental trial, 
coupled with the evidence from previous obser-
Table 4. Effect of supplementation on mean FTII scores and A-not-B Task odds ratios at 39- and 52-
weeks of age from multivariate models adjusted for cluster randomization-sex-caste-and dose1
Test
39-week visit
Outcome Placebo 
OR (95% CI)
Zinc 
OR (95% CI)
Iron-folic acid 
OR (95% CI)
Zinc-iron-folic 
acid 
OR (95% CI)
FTII Preference for 
novelty2
59.38
(57.52-61.25)
57.46
(55.47-59.44)
59.41
(57.65-61.17)
58.63
(55.79-61.47)
FTII Fixation 
duration3
1.42
(1.29-1.57)
1.40
(1.35-1.53)
1.32
(1.25-1.38)
1.46
(1.36-1.57)
A-not-B Task A-not-B error4 1.0 0.33
(0.20-0.56)
0.31
(0.09-1.06)
0.70
(0.34-1.41)
A-not-B Task Accurate 
performance5 1.0
0.18
(0.06-0.56)
0.17
(0.07-0.41)
0.38
(0.20-0.71)7
A-not-B Task Deteriorated 
performance6 1.0
0.41
(0.23-0.75)
0.95
(0.38-2.38)
0.24
(0.11-0.56)7
52-week visit
FTII Preference for 
novelty2
62.10
(60.86-63.35)
61.41
(58.02-64.79)
61.48
(60.04-62.91)
60.10
(58.84-61.36)7
FTII Fixation 
duration3
1.30
(1.26-1.34)
1.33
(1.27-1.39)
1.30
(1.27-1.34)
1.33
(1.28-1.39)
A-not-B Task A-not-B error4 1.0 0.30
(0.13-0.70)
0.40
(0.25-0.64)
0.48
(0.28-0.83)7
A-not-B Task Accurate 
performance5 1.0
0.59
(0.29-1.19)
0.48
(0.21-1.09)
0.37
(0.22-0.62)7
A-not-B Task Deteriorated 
performance6 1.0
0.16
(0.78-0.34)
0.16
(0.07-0.40)
0.14
(0.05-0.43)
1A-not-B Task outcomes were additionally adjusted for A-not-B flag and maximum delay. Dose and 
maximum delay were centred around their respective means; 2Preference for novelty: Raw FTII score; 
3Fixation duration: Time spent attending to the stimuli; 4A-not-B error: No more than 1 error on 
repeat-following-correct trial—at least 1 error on a reversal trial and either an error on at least one 
more reversal trial or an error on the trial immediately following the reversal error. Repeat-following-
correct: Side of hiding remains same, and subject was correct on previous trial; 5Accurate performance: 
≥85% correct; 6Deteriorated performance: <75% correct; >1 error on repeat-following-correct trials; 
7p<0.05; CI=Confidence interval; FTII=Fagan Test of Infant Intelligence; OR=Odds ratioSiegel EH et al. Iron and zinc supplementation and infant cognition
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vational studies with heterogeneous development 
outcomes, revealed little consistency in the effect 
of iron and/or zinc supplementation on indicators 
of infant cognition. 
Conclusions
These findings point to the need to elucidate the 
role of micronutrients in early cognitive develop-
ment and further explore the influence of gender 
on specific cognitive indicators. Future studies 
with fewer limitations will need to be designed to 
further investigate the effect of micronutrient sup-
plementation on the information-processing out-
comes among young micronutrient-deficient chil-
dren. Moreover, future research needs to address 
the broader contextual question of early cognitive 
development as children are frequently exposed to 
a host of factors that are not illuminated as part of 
the research design. In environments with signifi-
cant stressors, such as the stress of the ongoing civil 
insurgency that occurred throughout this study, 
supplementation with nutrients, such as magne-
sium and vitamin C, that are depleted from tissues 
and poorly absorbed when the body is engaged in 
sympathetic versus parasympathetic nervous activi- 
ty (50-52), may have a more pronounced effect on 
early brain development than iron and zinc. Re-
sults of recent human and animal studies provide 
evidence for negative effects of vitamin C and mag-
nesium deficiencies on neonatal brain function-
ing (53-55). Perhaps future supplementation trials 
aimed at impacting early cognitive development 
need to account for nutrient depletion due to the 
stress response.
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